reviewTop 1% cited

Antiangiogenesis in cancer therapy—endostatin and its mechanisms of action

Experimental Cell Research · 2005 · Vol. 312(5) · pp. 594–607

J Folkman✉(Harvard University)

Angiogenesis and VEGF in Cancer Cancer, Hypoxia, and Metabolism Cancer, Lipids, and MetabolismEndostatinAngiogenesisBiologyBroad spectrumCancerCancer researchCancer therapyPharmacologyDownregulation and upregulationBiochemistry

MeSH terms

AnimalsAntineoplastic AgentsClinical Trials as TopicDisease Models, AnimalHumansNeoplasmsNeovascularization, PathologicAngiogenesis InhibitorsEndostatins

Citations

654

FWCI

12.11

field-weighted impact

References

152

Percentile

99%

vs. same field & year

Citations per year

Cited by

Platelets, inflammation and tissue regeneration

Thrombosis and Haemostasis · 2011 · 779 citations

Angiogenesis: an organizing principle for drug discovery?

Nature Reviews Drug Discovery · 2007 · 2,228 citations

References

Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth

Cell · 1997 · 4,485 citations

Novel Antiangiogenic Effects of the Bisphosphonate Compound Zoledronic Acid

Journal of Pharmacology and Experimental Therapeutics · 2002 · 846 citations

Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer

New England Journal of Medicine · 2004 · 10,930 citations

Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth

Cell · 1997 · 4,485 citations

Antiangiogenesis in cancer therapy—endostatin and its mechanisms of action

Experimental Cell Research · 2005 · 654 citations

Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.